We discovered that TPD52 in PRAD samples was hypomethylation compared with adjacent normal ones, which is consistent with the observed upregulation of TPD52 in PRAD combined with DNA methyltransferase analysis (DNMT1, DNMT3A and DMNT3B). This evidence concerns the gene DNMT1 and prostate adenocarcinoma.